The importance of nonpharmacogenetic factors in endocrine therapy

Colin McCowan, Alastair Thompson

Research output: Contribution to journalReview article

6 Scopus citations

Abstract

Nonpharmacogenetic factors may play a key role in the success of oral endocrine therapy for breast cancer. Adherence, defined as following medical advice as well as persistence and duration of use for patients prescribed endocrine therapy, may impact significantly on recurrence and survival. Side effects from tamoxifen or aromatase inhibitors may lead to patients stopping or switching therapy, while comorbidities, consequent coprescribing and patient perceptions may also influence outcomes. Interventions to improve adherence and persistence are required and could have as great an effect on survival as applying pharmacogenetic principles to the endocrine management of breast cancer.

Original languageEnglish (US)
Pages (from-to)721-728
Number of pages8
JournalPharmacogenomics
Volume13
Issue number6
DOIs
StatePublished - Apr 1 2012

Keywords

  • adherence
  • aromatase inhibitors
  • breast cancer
  • persistence
  • tamoxifen

ASJC Scopus subject areas

  • Molecular Medicine
  • Genetics
  • Pharmacology

Fingerprint Dive into the research topics of 'The importance of nonpharmacogenetic factors in endocrine therapy'. Together they form a unique fingerprint.

  • Cite this